ELAN

Elanco Animal Health Incorporated Common Stock

HealthcareDrug Manufacturers - Specialty & GenericNYSE

$25.51

+10.96%today

MKT CAP

$12.7B

+5.7% · 1Y

Full Financials

Trailing P/E-

Forward P/E19.8x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR-

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership-

Institutional Ownership-

Short % of Float-

Days to Cover-

1 Week+4.5%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
RGC Regencell Bioscience Holdings Limited Ordinary Shares	$13.7B	23	-	-	-	-54.8%	0%	11.20	0.00%
RDY Dr. Reddy's Laboratories Ltd Common Stock	$11.2B	49	18.5	24.4	-	-	-	-	59.93%
NBIX Neurocrine Biosciences Inc. Common Stock	$14.6B	86	23.0	11.4	17.1	22.5%	65%	11.92	0.00%
VTRS Viatris Inc. Common Stock	$18.6B	58	-	6.4	8.2	-2.0%	39%	97.86	276.00%
UTHR United Therapeutics Corporation Common Stock	$25.3B	67	20.6	16.9	13.8	19.7%	88%	0.53	0.00%
HIMS Hims & Hers Health Inc. Class A Common Stock	$6.2B	48	50.3	18.6	36.4	25.2%	74%	207.16	0.00%